Literature DB >> 7551384

Nasal lavage cytokines in normal, allergic, and asthmatic school-age children.

T L Noah1, F W Henderson, M M Henry, D B Peden, R B Devlin.   

Abstract

Inflammation can be demonstrated in the airway mucosa of asthmatics, even in the absence of overt symptoms, but the pathogenesis of this chronic inflammation is incompletely defined. It has been suggested that inflammatory cytokines produced by epithelium may play important roles in this process. Therefore, we measured the cytokines interleukin-8 (IL-8), IL-6, and granulocyte-macrophage colony-stimulating factor (GM-CSF) in nasal lavage fluids from school-age children who were (1) "normal" (nonallergic/nonasthmatic), (2) allergic to house-dust mite antigen but nonasthmatic (no history of wheezing), or (3) allergic and asthmatic (history of > or = 10 wheezing episodes). Children underwent a single nasal lavage procedure while asymptomatic and on no anti-inflammatory medications or anti-histamines. In addition to cytokine concentrations, cell counts, differentials, albumin, histamine, and eosinophil cationic protein (ECP) concentrations were determined in nasal lavage fluids. Significant increases in IL-8 and ECP were observed in asthmatics compared with both normals and allergic nonasthmatics. Overall, IL-8 in nasal lavage fluids correlated significantly with ECP. Allergic nonasthmatics did not have significant increases in cytokines or other mediators compared with normal subjects. Concentrations of IL-6 did not differ significantly among the three groups, and GM-CSF was undetectable in all samples tested. We conclude that increased IL-8 production and eosinophil activation are characteristic of the airways of asthmatic children when asymptomatic, and we speculate that IL-8 plays a role in the maintenance of airway inflammation in asthma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7551384     DOI: 10.1164/ajrccm.152.4.7551384

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

1.  Newly divided eosinophils limit ozone-induced airway hyperreactivity in nonsensitized guinea pigs.

Authors:  Sarah A Wicher; David B Jacoby; Allison D Fryer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-03-03       Impact factor: 5.464

2.  Antioxidant supplementation and nasal inflammatory responses among young asthmatics exposed to high levels of ozone.

Authors:  J J Sienra-Monge; M Ramirez-Aguilar; H Moreno-Macias; N I Reyes-Ruiz; B E Del Río-Navarro; M X Ruiz-Navarro; G Hatch; K Crissman; R Slade; R B Devlin; I Romieu
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

3.  Indoor insect allergens are potent inducers of experimental eosinophilic esophagitis in mice.

Authors:  Madhavi Rayapudi; Parm Mavi; Xiang Zhu; Akhilesh K Pandey; J Pablo Abonia; Marc E Rothenberg; Anil Mishra
Journal:  J Leukoc Biol       Date:  2010-04-22       Impact factor: 4.962

Review 4.  Noninvasive effects measurements for air pollution human studies: methods, analysis, and implications.

Authors:  Jaime Mirowsky; Terry Gordon
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-01-21       Impact factor: 5.563

Review 5.  Host defense function of the airway epithelium in health and disease: clinical background.

Authors:  Simon D Message; Sebastian L Johnston
Journal:  J Leukoc Biol       Date:  2003-09-12       Impact factor: 4.962

6.  An adult model of exclusive viral wheeze: inflammation in the upper and lower respiratory tracts.

Authors:  M C Mckean; C Hewitt; P C Lambert; St Myint; M Silverman
Journal:  Clin Exp Allergy       Date:  2003-07       Impact factor: 5.018

7.  Enhanced severity of virus associated lower respiratory tract disease in asthma patients may not be associated with delayed viral clearance and increased viral load in the upper respiratory tract.

Authors:  Leontine J R van Elden; Alfred P E Sachs; Anton M van Loon; Monique Haarman; David A van de Vijver; Tjeerd G Kimman; Peter Zuithoff; Pauline J Schipper; Theo J M Verheij; Monique Nijhuis
Journal:  J Clin Virol       Date:  2007-12-21       Impact factor: 3.168

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.